Arrestin recruitment and signaling by G protein-coupled receptor heteromers-Reference-Cited by-同舟云学术

Arrestin recruitment and signaling by G protein-coupled receptor heteromers

Published:2019-07 Issue: Volume:152 Page:15-21
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Mores Kendall L.,Cassell Robert J.,van Rijn Richard M.^ORCID

Funder

National Institutes for Health to RMvR

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference77 articles.

1. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice;Abdelhamid;J. Pharmacol. Exp. Therapeut.,1991

2. Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle;Albee;Open Biol.,2018

3. FFAR2-FFAR3 receptor heteromerization modulates short-chain fatty acid sensing;Ang;Faseb. J.,2018

4. Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function;Angers;Annu. Rev. Pharmacol. Toxicol.,2002

5. Antagonism of dopamine receptor 2 long affects cannabinoid receptor 1 signaling in a cell culture model of striatal medium spiny projection neurons;Bagher;Mol. Pharmacol.,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apelin receptor dimer: Classification, future prospects, and pathophysiological perspectives;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-08

2. Stabilised D₂R G-protein coupled receptor oligomers identify multi-state β-arrestin complexes;2024-07-16

3. Exploiting Cell-Based Assays to Accelerate Drug Development for G Protein-Coupled Receptors;International Journal of Molecular Sciences;2024-05-17

4. Activation of dimerized BRS3-EP3 suppresses melanoma cell migration through coupling Gαs protein;Fundamental Research;2024-04

5. Growth Factor Receptor Implications in Breast Cancer: Prospects for Their Molecular Transactivation in the Future and Obstacles for Target Therapy;Interdisciplinary Cancer Research;2024